A human pathophysiological 3D-bone marrow model reveals immune and stromal cell heterogeneity. [PDF]
Giannini M +10 more
europepmc +1 more source
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03. [PDF]
Trédan O +22 more
europepmc +1 more source
Postcancer rehabilitation: multidisciplinary exercise - programme organisation and feasibility. [PDF]
Drozd C +20 more
europepmc +1 more source
<i>Babesia hegotelforum</i> sp. nov., a zoonotic <i>Babesia</i> species previously referred to as <i>Babesia sp</i>. <i>MO1</i>. [PDF]
Singh P +11 more
europepmc +1 more source
Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]. [PDF]
Garassino MC +20 more
europepmc +1 more source
Éditorial / Editorial Numéro spécial sur la médecine personnalisée / Special issues on personalized medecin [PDF]
Darrason, Marie, Giroux, Élodie
core
Oncotype Dx Breast Cancer Assay in Older Patients: A Real Life Cohort. [PDF]
Grosnon C +11 more
europepmc +1 more source
From genetic risk to early detection - clinical outcomes of a person-centered screening program for women with a high genetic risk of breast cancer. [PDF]
Zhou K +5 more
europepmc +1 more source
Traitement potentiel du cancer de la prostate : synthèse et activité cytotoxique de nouveaux dérivés de testostérone [PDF]
Bruneau, Julie
core

